Across TCGA pan-cancer cohorts, MYO5BP3 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MYO5BP3’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where MYO5BP3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MYO5BP3 is over-expressed in tumor.
COAD and KICH are the cancer types where MYO5BP3 tumor–normal differential expression is most reproducible.